The new Princeton, NJ-based office is the result of a multimillion-dollar investment and continued growth driven by an increasing use of medical imaging in clinical research.
To simplify the human biospecimens procurement process, the online marketplace for outsourced scientific services, Scientist.com, has teamed up with iSpecimen.
Researchers developing a method to determine drug bioavailability say the approach could become a ‘shortcut’ for scientists in drug discovery and development.
Pharmaceutical Product Development, LLC (PPD) has combined its medical affairs research operations (MARO) team and Evidera to create a dedicated real-world research and market access unit.
NovAliX has signed an insourcing agreement with UCB Biopharma, a model that the CRO says “energizes scientific organization” and offers "significant" cost advantages.
The Global Biological Standards Institute (GBSI) has outlined an action plan after finding the frequency of irreproducible preclinical research exceeds 50% – costing the US nearly $28bn.
The US Food and Drug Administration (FDA) has signed an agreement with CluePoints to "further explore" a data-driven approach to quality oversight in clinical trials.
The open-source study was launched in order to advance understanding of real-world experience with therapies and clinical outcomes in patients with multiple myeloma.
The US spends billions on preclinical research that cannot be replicated due to errors in design, problems with lab protocols and mistakes during data analysis according to new research.
Inform Genomics has selected Icon as its contract research organization (CRO) for the pivotal multicenter study of its Hematopoietic Stem Cell Transplant (HSCT)/Mucositis product candidate.
Animal-model contract research organisation (CRO) Crown Bioscience will open a research centre in North Carolina, combining expanded oncology services with its existing cardiovascular and metabolic offerings.
Roche has clashed with the authors of a report slamming the efficacy of Tamiflu, each claiming the other’s analysis of patient data is seriously flawed.
With a growing demand for comparative effectiveness data and questions on quality research persisting, Quintiles teamed with the National Pharmaceutical Council to develop and test a checklist to evaluate the quality and usefulness of observational research...
Quintiles has bought its way into the observational research space with the acquisition of Outcome Sciences and strengthened its market access standing with the purchase of VCG & Associates.
ATMI LifeSciences has introduced a new method of integrity testing for its range of single-use bioprocess vessels that, it claims, will take QA in the biomanufacturing sector to a new level.
US Contract research laboratory Metrics reveals that benzophenone, a component used in varnish on labels, is able to migrate through HDPE bottles to reach the pills inside.
Clinical software developer, Forte Research Systems, has opened a new office in Bangalore, India, to take advantage of growth in the clinical research industry on the sub-continent.
Applied Clinical Intelligence (ACI) has launched iCommittees to provide a platform to support sponsors’ needs for clinical endpoint adjudication and data monitoring committees (DMC).
RXi Pharmaceuticals has applied its sd-rxRNA to dermal cells, establishing the efficacy of the technology as it seeks to move it on to the next stage of development, a company VP told in-PharmaTechnologist.
The US Food and Drug Administration (FDA) has issued guidance on the use of Bayesian analysis in clinical trials of medical devices and says the technique can cut costs and boost efficiency.
European ScreeningPort is using IDBS’ ActivityBase XE to manage growing demand for screening services from the academic institutes which outsource to it.
GEA Pharma Systems’ process equipment is now available with its Lighthouse Probe technology, which uses fibre optics and mirrors to give a clear view of the product when it is in the machine.
GE Healthcare’s range of AxiChrom columns will simplify manufacturing operations, improve reproducibility and allow for faster change over according to company senior product manager, Per Karlberg.
A company based in the US and Germany has set up what it describes
as a 'Facebook for scientists', in a move that brings the
phenomenon of social networking firmly into the workplace.
LabTechnologist.com brings you a round up of some of the latest
product releases with new offerings from Agilent, Applied
Biosystems, ESA Biosciences, Illumina, Mettler-Toledo and Syrris.
A new clinical research tool is now available, offering
investigators the ability to integrate clinical data from a number
of different sources across the clinical development spectrum.
The Pharmaceutical Institute, provider of specialised knowledge for
the pharma industry, is now providing custom research services to
cater for those with complex research needs.
Freeman Technology introduces its new aeration control unit for its
FT4 Powder Rheometer, which allows airflow control through a powder
under test, enabling the automated measurement of the powder's flow
properties.
Scientists in research and academia have called for the end to the
pharmaceutical industry's 'cynical use' of drug studies and its
subjects who are often misled into taking part.
Medical research bodies have joined together in a defiant effort to
combat terrorism by issuing a statement that aims to reduce the
risk of sensitive laboratory research being used in bioterrorism.
A new in silico technique for generating enhanced predictions for
ADME/Tox research could have new implications in developing novel
drug techniques in combating drug-resistant infectious diseases and
cancer.
Materials testing specialist Stable Micro Systems has launched a
texture analysis device which promises to increase productivity and
improve cost-effectiveness where higher volume, repetitive quality
testing is required.
GeneGo has launched an ADME/Tox platform which combines software
for predicting metabolites and over 40 ADME/Tox properties
properties with visualization and analysis of toxicogenomics and
metabolomics data.
Accelrys has signed a $21.5 million (€17.6 million) agreement to
merge SciTegic with one of its subsidiaries in a deal that will add
additional data analysis and mining software design capabilities to
Accelrys' extensive portfolio...
MediGene is relocating the entire research department of its US
subsidiary to Germany, delighting those who lament the "brain
drain" of scientific talent flowing in the other direction
